Depot risperidone for schizophrenia
is a topic covered in the Evidence-Based Medicine Guidelines
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
"Depot Risperidone for Schizophrenia." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/454865/all/Depot_risperidone_for_schizophrenia.
Depot risperidone for schizophrenia. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/454865/all/Depot_risperidone_for_schizophrenia. Accessed October 17, 2019.
Depot risperidone for schizophrenia. (2019). In Evidence-Based Medicine Guidelines. Available from https://evidence.unboundmedicine.com/evidence/view/EBMG/454865/all/Depot_risperidone_for_schizophrenia
Depot Risperidone for Schizophrenia [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2019 October 17]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/454865/all/Depot_risperidone_for_schizophrenia.
TY - ELEC
T1 - Depot risperidone for schizophrenia
ID - 454865
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/454865/all/Depot_risperidone_for_schizophrenia
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine